The Department's National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including fibromyalgia. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.
The researcher-led workstream of the Efficacy and Mechanism Evaluation programme is funded by the Medical Research Council and managed by the NIHR. This programme funds clinical efficacy studies and is currently open to applications, including applications in fibromyalgia. The programme also provides an opportunity to use clinical studies to understand disease or treatment mechanisms.